After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, MNMD falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Mind Medicine Inc is $670.91M. A total of 1.25 million shares were traded on the day, compared to an average of 1.14M shares.
In the most recent transaction, Sullivan Mark sold 11,491 shares of MNMD for 6.80 per share on Jun 25 ’25. After the transaction, the Chief Legal Officer now owns 305,130 company shares. In a previous transaction on Jun 25 ’25, Karlin Daniel sold 7,848 shares at 6.80 per share. MNMD shares that Chief Medical Officer owns now total 438,329.
Among the insiders who sold shares, Barrow Robert disposed of 26,491 shares on Jun 25 ’25 at a per-share price of $6.80. This resulted in the Chief Executive Officer holding 830,065 shares of MNMD after the transaction. In another insider transaction, DANIEL ROLLINGS KARLIN bought 7,848 shares at $6.80 per share on Jun 25 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, MNMD has a high of $10.44 and a low of $4.70.
As of this writing, MNMD has an earnings estimate of -$0.36 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.29 per share and a lower estimate of -$0.4.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. MNMD’s latest balance sheet shows that the firm has $133.54M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $10.41M in liabilities at the time. Its Book Value Per Share was $2.95, while its Total Shareholder’s Equity was $151.66M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MNMD is Buy with a score of 4.90.
